United States Digital Diabetes Management Market 2031 | Growth Drivers, Key Players & Investment Opportunities

Market Size and Growth

Digital Diabetes Management Market reached US$ 16.58 billion in 2024 and is expected to reach US$ 38.37 billion by 2033, growing at a CAGR of 10.3% during the forecast period of 2025-2033.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/digital-diabetes-management-market?sb

Key Development:

United States: Recent Digital Diabetes Management Developments

✅ In December 2025, the U.S. Centers for Medicare & Medicaid Services launched the ACCESS Medicare payment trial to support digital care for chronic conditions including diabetes, shifting reimbursement toward outcome‐based remote monitoring and digital tools.

✅ In November 2025, Tandem Diabetes Care received FDA clearance for the Android version of its Mobi mobile app, expanding smartphone‐based control of its automated insulin delivery system in the U.S. and enhancing user‐centric digital management.

✅ In November 2025, Roche received a CE Mark for its Accu‐Chek SmartGuide CGM with mySugr app integration, advancing predictive CGM and app‐based diabetes data management for users in markets aligned with U.S. digital health trends.

✅ In September 2025, Amazon partnered with nutrition‐care startup Fay to integrate personalized, insurance‐covered dietitian and coaching services into its digital health offerings, strengthening digital diabetes support in the U.S. market.

✅ In September 2025, Glooko announced the acquisition of Monarch Medical Technologies, the developer of the EndoTool Glucose Management System, expanding its diabetes digital health platform into inpatient and hospital‐to‐home glycemic management and strengthening its connected diabetes care offerings.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=digital-diabetes-management-market

Japan: Recent Digital Diabetes Management Developments

✅ In December 2025, Sanofi extended its digital diabetes partnership with Health2Sync in Japan, enhancing connected patient apps with automated dose logging and adherence support to improve glucose control.

✅ In November 2025, APAC digital health funding reports highlighted Japan as a regional hotspot for digital health investment and partnerships, including chronic care and diabetes‐focused platforms, signaling broader capital interest in Japanese digital diabetes solutions.

✅ In November 2025, CHA Bio Group agreed to acquire a controlling stake in Kakao Healthcare, giving it majority ownership and operational control of the AI‐driven digital health and chronic disease platform (including diabetes management tools), positioning the business for broader regional digital healthcare expansion

✅ In October 2025, industry reporting noted increased integration of AI‐driven personalization in Japanese diabetes digital therapeutics and wearable CGM ecosystems, supporting remote care for aging and chronic patient populations.

✅ In October 2025, Japan's digital therapeutic landscape continued to expand regulatory support, with increased product approvals and national insurer coverage improving access to software‐led diabetes care tools.

Key Players:

=> Abbott, Dexcom, Inc., F. Hoffmann-La Roche Ltd, Medtronic, and Insulet Corporation. Tandem Diabetes Care, Inc., Ascensia Diabetes Care Holdings AG., LifeScan IP Holdings, LLC., AgaMatrix, and Ypsomed AG among others.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/digital-diabetes-management-market?sb

Key Segments:

By Product & Service

Devices lead with 45% share, driven by the rising adoption of glucose monitoring systems, insulin delivery devices, and integrated diabetes care tools. Digital Diabetes Management Apps account for 20%, supported by growing smartphone penetration, telehealth adoption, and demand for personalized diabetes care. Data Management Software & Platforms hold 25%, fueled by the need for real-time patient monitoring, analytics, and integration with healthcare systems. Other products and services make up 10%, including patient engagement tools, coaching platforms, and ancillary diabetes management solutions.

By Device Type

Handheld devices dominate with 55% share, driven by traditional glucometers, portable insulin pens, and point-of-care monitoring systems. Wearable devices account for 45%, reflecting growing adoption of continuous glucose monitors (CGMs), smart patches, and wearable insulin delivery systems for real-time data and improved patient compliance.

By End-User

Self/Home Healthcare leads with 50% share, fueled by patient preference for convenient at-home monitoring, telehealth integration, and increased awareness of self-management practices. Hospitals & Specialty Diabetes Clinics account for 25%, supported by clinical monitoring, advanced treatment, and integration with electronic health records. Academic & Research Institutes hold 15%, driven by clinical trials, epidemiological studies, and device validation research. Other end-users represent 10%, including corporate wellness programs, insurance initiatives, and community healthcare centers.

By Region

North America - 35% Share
North America leads with 35%, driven by high prevalence of diabetes, advanced healthcare infrastructure, and strong adoption of digital health solutions in the U.S. and Canada.

Europe - 28% Share
Europe holds 28%, supported by growing adoption of connected devices, advanced healthcare reimbursement policies, and increasing awareness in Germany, France, U.K., Italy, Spain, and neighboring countries.

Asia Pacific - 25% Share
Asia Pacific accounts for 25%, fueled by rising diabetes prevalence, expanding healthcare infrastructure, and growing adoption of digital and wearable diabetes management solutions in China, India, Japan, and Southeast Asia.

Middle East & Africa - 7% Share
The Middle East & Africa represent 7%, supported by emerging digital health initiatives, increasing investment in diabetes care, and government health programs in GCC countries and South Africa.

South America - 5% Share
South America holds 5%, driven by growing awareness, adoption of portable devices, and healthcare modernization in Brazil, Mexico, and surrounding regions.

FAQ

What is the current size of the Digital Diabetes Management Market?

A: In 2024, the Digital Diabetes Management Market was valued at US$ 16.58 billion, reflecting its strong industry presence.

Q2: How large is the Digital Diabetes Management Market expected to be by 2033?

A: By 2033, industry forecasts suggest the Digital Diabetes Management Market will grow to around US$ 38.37 billion, demonstrating significant expansion.

Q3: What is the growth rate of the Digital Diabetes Management Market?

A: The market is projected to expand at a compound annual growth rate (CAGR) of 10.3% during the forecast period from 2025 to 2033.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg?sb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.